Skip to main content
HairCited

研究プロセス

150 査読済み研究からの図表

すべて セレン ケラチン コラーゲン ミノキシジル デュタステリド フィナステリド スピロノラクトン ローズマリーオイル マイクロニードリング オメガ3脂肪酸 ビタミンB12 ビタミンD L-システイン MSM PRP療法 亜鉛 低出力レーザー治療 カフェイン（外用） 鉄
All Types Chart Diagram Photograph Flowchart Forest Plot Micrograph Other
Fig. 1 Representative dermoscopic image from enrolled subjects at baseline showing yellow dots (black arrow), black dots (black triangle), dystrophic hairs (white arrow) and exclamation mark (white triangle)
Figure 1

Fig. 1 Representative dermoscopic image from enrolled subjects at baseline showing yellow dots (black arrow), black dots (black triangle), dystrophic hairs (white arrow) and exclamation mark (white triangle)

Efficacy of Postbiotics in a PRP-Like Cosmetic Product for the Treatment of …

Fig. 2 Representative dermoscopic image from enrolled subjects at baseline (T0)
Figure 2

Fig. 2 Representative dermoscopic image from enrolled subjects at baseline (T0)

Efficacy of Postbiotics in a PRP-Like Cosmetic Product for the Treatment of …

Fig. 3 Digital photographs from three different subjects (a, b, c). Baseline (T0), 3 months of treatment (T2)
Figure 3

Fig. 3 Digital photographs from three different subjects (a, b, c). Baseline (T0), 3 months of treatment (T2)

Efficacy of Postbiotics in a PRP-Like Cosmetic Product for the Treatment of …

Figure 1
Figure 1

Insomnia and Restless Leg Syndrome in Patients Undergoing Chronic Hemodialysis in Rafsanjan …

Figure 2
Figure 2

Insomnia and Restless Leg Syndrome in Patients Undergoing Chronic Hemodialysis in Rafsanjan …

Figure 2
Figure 2

Hair Growth Promoting Effects of 650 nm Red Light Stimulation on Human …

Figure 3
Figure 3

Hair Growth Promoting Effects of 650 nm Red Light Stimulation on Human …

Figure 1
Figure 1

Tolerability of long-term cannabidiol supplementation to healthy adult dogs.

Figure 2
Figure 2

Tolerability of long-term cannabidiol supplementation to healthy adult dogs.

Figure 3
Figure 3

Tolerability of long-term cannabidiol supplementation to healthy adult dogs.

Figure 4
Figure 4

Tolerability of long-term cannabidiol supplementation to healthy adult dogs.

Figure 1: Step-by-step flow diagram of preparation of platelet-rich plasma using open double-spin method
Figure 1

Figure 1: Step-by-step flow diagram of preparation of platelet-rich plasma using open double-spin method

Platelet-Rich Plasma in Androgenetic Alopecia.

Figure 1
Figure 1

Sleep-promoting activity of amylase-treated Ashwagandha (Withania somnifera L. Dunal) root extract via …

Figure 4
Figure 4

Sleep-promoting activity of amylase-treated Ashwagandha (Withania somnifera L. Dunal) root extract via …

Figure 5
Figure 5

Sleep-promoting activity of amylase-treated Ashwagandha (Withania somnifera L. Dunal) root extract via …

Figure 1
Figure 1

Association of Alopecia Areata with Vitamin D and Calcium Levels: A Systematic …

Figure 2
Figure 2

Association of Alopecia Areata with Vitamin D and Calcium Levels: A Systematic …

Figure 3
Figure 3

Association of Alopecia Areata with Vitamin D and Calcium Levels: A Systematic …

Figure 4
Figure 4

Association of Alopecia Areata with Vitamin D and Calcium Levels: A Systematic …

Figure 2
Figure 2 Forest Plot

Forest plot or pooled analysis from the spironolactone meta-analysis, presenting combined efficacy data across studies examining oral spironolactone for treating female pattern hair loss.

The Efficacy and Safety of Oral Spironolactone in the Treatment of Female …

Figure 3
Figure 3 Chart

Risk of bias or quality assessment for studies included in the spironolactone and female pattern hair loss meta-analysis, evaluating methodological rigor across the evidence base.

The Efficacy and Safety of Oral Spironolactone in the Treatment of Female …

The hair loss did not improve or showed a modest improvement in 37.80% (95% CI=24.88-52.71) of all patients. Further subgroup analysis showed that the rate was 31.93% (95% CI=17.17-51.49) in the combined therapy and 46.73% (95% CI=30.93-63.21) in the mono
Figure 4 Forest Plot

Pooled analysis indicating that hair loss did not improve or showed only modest improvement in 37.80% (95% CI: 24.88-52.71%) of patients treated with oral spironolactone, with subgroup analyses revealing variable response rates.

The Efficacy and Safety of Oral Spironolactone in the Treatment of Female …

Figure 5
Figure 5 Chart

Safety outcomes or adverse event analysis from the spironolactone meta-analysis, summarizing the tolerability profile of oral spironolactone when used for female pattern hair loss.

The Efficacy and Safety of Oral Spironolactone in the Treatment of Female …

FIGURE 1: Initial status (A), minimal regrowth six weeks after the second injection (B), robust regrowth at one-year follow-up (C).
Figure 2 Photograph

Serial photographs document the treatment response to platelet-rich plasma injections, showing minimal regrowth at six weeks after the second injection followed by robust regrowth at one-year follow-up.

Successful Treatment of Alopecia Areata Barbae with Platelet-rich Plasma.

7ページ中5ページ目